Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas E Stinchcombe
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Carle Cancer Center Nci Community Oncology Research Program
Urbana, Illinois, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Cancer Research Consortium of West Michigan Ncorp
Grand Rapids, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Coborn Cancer Center at Saint Cloud Hospital
Saint Cloud, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- New Hampshire Oncology Hematology Pa-Hooksett
Hooksett, New Hampshire, United States
- Hematology Oncology Associates of Central New York-East Syracuse
East Syracuse, New York, United States
- State University of New York Upstate Medical University
Syracuse, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Sanford Broadway Medical Center
Fargo, North Dakota, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Upstate Carolina Ccop
Spartanburg, South Carolina, United States
- Rapid City Regional Hospital
Rapid City, South Dakota, United States
- Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Mar 2012
- Primary completion
- 13 Feb 2018
- Completion
- 18 Aug 2020
- Last update posted
- 6 Oct 2020
- Registered enrollment
- 88
- Registry id
- NCT01532089
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.